Alle Filter zurücksetzen
Kategorien
  • Pharma / Gesundheit
  • Pharmaindustrie / Medikamente
  • Hormone / Stoffwechsel
  • Filter zurücksetzen
Regionen/Länder
  • Europa
  • Deutschland
  • Frankreich
  • Italien
  • Spanien
  • Vereinigtes Königreich
  • Asien / Pazifik
  • China
  • Japan
  • Vietnam
  • Mittlerer Osten / Afrika
  • Nordamerika / USA
  • Australien
  • Mittel- / Südamerika
  • Filter zurücksetzen
Herausgeber
  • Datamonitor
  • Euromonitor
  • GBI Research
  • Global Markets Direct
  • GlobalData
  • Life Science Analytics
  • Technavio
  • Filter zurücksetzen
Sprache
  • Englisch
  • Filter zurücksetzen
Datum
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • Filter zurücksetzen
laedt

Marktanalyse - Gestational Diabetes Global Clinical Trials Review, H1, 2012

GlobalData

GlobalData

5 / 2012
78 Seiten
Typ: Marktanalyse
Sprache: Englisch
Regionen: Europa, Asien / Pazifik, Mittlerer Osten / Afrika, Nordamerika / USA, Australien, Mittel- / Südamerika
Verfügbarkeit: verfügbar

Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:

768,34 €*
( 1.000,00 $)
PDF-Datei per E-Mail, Single User Price , versandkostenfrei
1.536,69 €*
( 2.000,00 $)
PDF-Datei per E-Mail, Site License Price** , versandkostenfrei
2.305,03 €*
( 3.000,00 $)
PDF-Datei per E-Mail, Enterprisewide Price (Global Site License)*** , versandkostenfrei


Gestational Diabetes Global Clinical Trials Review, H1, 2012


Summary


GlobalData's clinical trial report, 'Gestational Diabetes Global Clinical Trials Review, H1, 2012' provides data on the Gestational Diabetes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gestational Diabetes. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gestational Diabetes. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)


Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Gestational Diabetes 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by BRIC Nations 15

Clinical Trials by G7 Nations 16

Clinical Trials in G7 Nations by Trial Status 17

Clinical Trials by E7 Nations 18

Clinical Trials in E7 Nations by Trial Status 19

Clinical Trials by Phase 20

In Progress Trials by Phase 21

Clinical Trials by Trial Status 22

Unaccomplished Trials of Gestational Diabetes 23

Subjects Recruited Over a Period of Time 25

Prominent Sponsors 26

Top Companies Participating in Gestational Diabetes Therapeutics Clinical Trials 28

Prominent Drug Comparison 29

Clinical Trial Profiles 30

Clinical Trial Overview of Top Companies 30

Xanodyne Pharmaceuticals, Inc. 30

Clinical Trial Overview of Xanodyne Pharmaceuticals, Inc. 30

InLight Solutions Inc. 31

Clinical Trial Overview of InLight Solutions Inc. 31

Intermountain Healthcare, Inc. 32

Clinical Trial Overview of Intermountain Healthcare, Inc. 32

Novo Nordisk A/S 33

Clinical Trial Overview of Novo Nordisk A/S 33

VeraLight, Inc. 34

Clinical Trial Overview of VeraLight, Inc. 34

Clinical Trial Overview of Top Universities / Institutes / Hospitals 35

Brigham and Women's Hospital 35

Clinical Trial Overview of Brigham and Women's Hospital 35

University of Toronto 36

Clinical Trial Overview of University of Toronto 36

University of Sherbrooke 37

Clinical Trial Overview of University of Sherbrooke 37

Kaiser Permanente 38

Clinical Trial Overview of Kaiser Permanente 38

VU University Medical Center 39

Clinical Trial Overview of VU University Medical Center 39

University of Messina 40

Clinical Trial Overview of University of Messina 40

BC Women's Hospital & Health Centre 41

Clinical Trial Overview of BC Women's Hospital & Health Centre 41

The University of Sydney 42

Clinical Trial Overview of The University of Sydney 42

University of Sao Paulo 43

Clinical Trial Overview of University of Sao Paulo 43

University of Oulu 44

Clinical Trial Overview of University of Oulu 44

The University of Texas Southwestern Medical Center at Dallas 45

Clinical Trial Overview of The University of Texas Southwestern Medical Center at Dallas 45

Turku University Hospital 46

Clinical Trial Overview of Turku University Hospital 46

Soroka University Medical Center 47

Clinical Trial Overview of Soroka University Medical Center 47

Shahid Sadoughi University of Medical Sciences and Health Services 48

Clinical Trial Overview of Shahid Sadoughi University of Medical Sciences and Health Services 48

Tianjin Women and Children's Health Center 49

Clinical Trial Overview of Tianjin Women and Children's Health Center 49

University of Otago 50

Clinical Trial Overview of University of Otago 50

University of California, Los Angeles 51

Clinical Trial Overview of University of California, Los Angeles 51

Georgetown University 52

Clinical Trial Overview of Georgetown University 52

University of Colorado 53

Clinical Trial Overview of University of Colorado 53

Sun Yat-sen University 54

Clinical Trial Overview of Sun Yat-sen University 54

Five Key Clinical Profiles 55

Appendix 75

Abbreviations 75

Definitions 75

Research Methodology 76

Secondary Research 76

About GlobalData 77

Contact Us 77

Disclaimer 77

Source 78





List of Tables

Gestational Diabetes Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7

Gestational Diabetes Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8

Gestational Diabetes Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9

Gestational Diabetes Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 10

Gestational Diabetes Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 11

Gestational Diabetes Therapeutics Clinical Trials, North America, Top Countries, 2012* 12

Gestational Diabetes Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 13

Gestational Diabetes Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 14

Gestational Diabetes Therapeutics Clinical Trials, BRIC Countries, 2012* 15

Gestational Diabetes Therapeutics Clinical Trials, G7 Countries, 2012* 16

Gestational Diabetes Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 17

Gestational Diabetes Therapeutics Clinical Trials, E7 Countries, 2012* 18

Gestational Diabetes Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 19

Gestational Diabetes Therapeutics Market, Global, Clinical Trials by Phase, 2012* 20

Gestational Diabetes Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 21

Gestational Diabetes Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 22

Gestational Diabetes Therapeutics Market, Global, Suspended Clinical Trials, 2012* 23

Gestational Diabetes Therapeutics Market, Global, Terminated Clinical Trials, 2012* 24

Gestational Diabetes Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 25

Gestational Diabetes Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 27

Gestational Diabetes Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 28

Gestational Diabetes Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 29

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Xanodyne Pharmaceuticals, Inc., 2012* 30

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by InLight Solutions Inc., 2012* 31

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Intermountain Healthcare, Inc., 2012* 32

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo Nordisk A/S, 2012* 33

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by VeraLight, Inc., 2012* 34

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2012* 35

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Toronto, 2012* 36

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sherbrooke, 2012* 37

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaiser Permanente, 2012* 38

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2012* 39

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Messina, 2012* 40

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by BC Women's Hospital & Health Centre, 2012* 41

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Sydney, 2012* 42

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2012* 43

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oulu, 2012* 44

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Southwestern Medical Center at Dallas, 2012* 45

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Turku University Hospital, 2012* 46

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Soroka University Medical Center, 2012* 47

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Sadoughi University of Medical Sciences and Health Services, 2012* 48

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Tianjin Women and Children's Health Center, 2012* 49

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Otago, 2012* 50

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012* 51

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Georgetown University, 2012* 52

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2012* 53

Gestational Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2012* 54





List of Figures

Gestational Diabetes Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7

Gestational Diabetes Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8

Gestational Diabetes Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9

Gestational Diabetes Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 10

Gestational Diabetes Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 11

Gestational Diabetes Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12

Gestational Diabetes Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 13

Gestational Diabetes Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 14

Gestational Diabetes Therapeutics Clinical Trials, BRIC Countries (%), 2012* 15

Gestational Diabetes Therapeutics Clinical Trials, G7 Countries (%), 2012* 16

Gestational Diabetes Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 17

Gestational Diabetes Therapeutics Clinical Trials, E7 Countries (%), 2012* 18

Gestational Diabetes Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 19

Gestational Diabetes Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 20

Gestational Diabetes Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 21

Gestational Diabetes Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 22

Gestational Diabetes Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 25

Gestational Diabetes Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 26

Gestational Diabetes Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 28

Gestational Diabetes Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 29

GlobalData Methodology 76

*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.

Hinweise: **The report can be shared by users within one office (one geographical location) ***Across Geographical locations (by the purchasing company only)

Für Sie protokollierte Studien / Marktanalysen:
  zuletzt angesehene Studien: